Research ArticleDiabetes

Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator

See allHide authors and affiliations

Science Translational Medicine  16 Jan 2019:
Vol. 11, Issue 475, eaau3441
DOI: 10.1126/scitranslmed.aau3441
PDF Container

Stay Connected to Science Translational Medicine

Navigate This Article